Loading
1 insider bought €15k of shares over the last 90 days, the latest by PERMATA HEALTH NUSANTARA, filed 19 Oct 2026.
MULTISARANA INTAN EDUKA Tbk, PT is a listed company. Its directors and officers file their transactions with OJK / IDX. In the past year (20 October 2025 to 20 October 2026), 3 filings came from 1 insider.
Only purchases show up on the open market, 3 purchases in all worth €19k, filed by 1 insider. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Permata Health Nusantara filed the largest purchase, €13k, on 19 October 2026. Among those who bought: 1 major shareholder.
The clock since the last published purchase (19 October 2026) now reads 6 days. Filings reach the OJK / IDX feed a median of 3 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done.
Compared with its exchange (288 companies, median 3 filings), a count of 3 filings is typical. Over the whole record (from 2026), the tally stands at 3 purchases and no sales.
Every figure here comes from the filings published by OJK / IDX and describes the past, not future prices; it is not investment advice.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
3 of 3 declarations
MULTISARANA INTAN EDUKA Tbk, PT is a publicly traded company on the Indonesia Stock Exchange, specializing in the education sector. It focuses on the development and management of educational institutions.
Insider filings
Over the last 90 days, 3 filings published between 27 July and 19 October 2026: 3 open-market purchases by insiders for €19k. Largest amounts: PERMATA HEALTH NUSANTARA (Pemegang Saham >=5% (Shareholder)), purchases of €19k.
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 21 October 2026 (UTC)